Journal of Experimental & Clinical Cancer Research,
Journal Year:
2025,
Volume and Issue:
44(1)
Published: May 2, 2025
Abstract
Extracellular
vesicles
(EVs),
particularly
engineered
variants,
have
emerged
as
promising
tools
in
cancer
immunotherapy
due
to
their
inherent
ability
modulate
immune
responses
and
deliver
therapeutic
agents
with
high
specificity
minimal
toxicity.
These
nanometer-sized
vesicles,
which
include
exosomes
(Exos)
other
subtypes,
naturally
participate
intercellular
communication
are
capable
of
carrying
a
diverse
range
bioactive
molecules,
including
proteins,
lipids,
RNAs,
metabolites.
Recent
advancements
the
biogenesis
EVs,
such
strategies
modify
surface
characteristics
cargo,
significantly
expanded
potential
effective
vehicles
for
targeted
therapies.
Tailoring
contents
incorporating
immunomodulatory
molecules
or
gene-editing
(GETs),
has
shown
outcomes
enhancing
anti-tumor
immunity
overcoming
immunosuppressive
tumor
microenvironment
(TME).
Moreover,
optimizing
delivery
mechanisms,
through
both
passive
active
targeting
strategies,
is
crucial
improving
clinical
efficacy
EV-based
This
review
provides
an
overview
recent
developments
engineering
EVs
immunotherapy,
focusing
on
biogenesis,
methods
content
customization,
innovations
cargo
delivery.
Additionally,
addresses
challenges
associated
translation
therapies,
issues
related
scalability,
safety,
By
offering
insights
into
current
state
field
identifying
key
areas
future
research,
this
aims
advance
application
treatment.
Pharmaceutics,
Journal Year:
2025,
Volume and Issue:
17(3), P. 326 - 326
Published: March 3, 2025
Exosomes,
spherical
lipid-bilayered
particles
secreted
by
cells,
have
recently
emerged
as
a
novel
and
highly
promising
drug
delivery
system,
attracting
extensive
attention
in
the
field
of
biomedical
research.
Dendritic-cell-derived
exosomes
(DC-Exos)
possess
surface
protein
ligands
characteristic
DC
such
functional
MHC-I
MHC-II,
CD80,
CD86.
These
components
play
crucial
role
immune
responses,
facilitating
antigen
uptake,
presentation,
activation
antigen-specific
CD4
CD8
T
cells.
properties
make
them
striking
excellent
vehicles
for
use
various
diseases
cancer
therapy.
This
review
summarizes
discusses
characteristics,
current
methods
types
loading
DC-Exos.
Its
modifications
application
disease
treatment
were
also
discussed,
aiming
to
motivate
development
exosome-based
theranostic
nanoplatforms
nanotechnology
improved
healthcare
treatments.
Journal of Nanobiotechnology,
Journal Year:
2025,
Volume and Issue:
23(1)
Published: March 8, 2025
The
liver,
functioning
as
an
endocrine
organ,
secretes
a
variety
of
substances
that
influence
the
activities
other
body
organs.
Conversely,
molecules
generated
by
organs
such
bone,
gut,
and
adipose
tissue
can
also
impact
liver
function.
Accumulating
evidence
suggests
bidirectional
communication
between
However,
research
on
how
extracellular
vesicles
(EVs),
which
transport
active
molecular
mediators,
contribute
to
this
interorgan
is
still
in
its
nascent
stages.
EVs
are
capable
transporting
functional
molecules,
including
lipids,
nucleic
acids,
proteins,
thereby
affecting
recipient
cells
across
different
at
biological
level.
This
review
examines
role
facilitating
cardiovascular
system,
pancreas,
brain,
lungs,
kidneys,
tissue.
It
explores
their
potential
disease
treatment
highlights
challenges
understanding
EV-mediated
interactions.
contribution
mediator-carrying
two-way
remains
area
ongoing
investigation.
Future
will
provide
more
comprehensive
theoretical
foundation
clarify
precise
mechanisms
governing
organs,
pinpoint
medical
targets,
expand
application
within
realm
precision
medicine.
Artificial Cells Nanomedicine and Biotechnology,
Journal Year:
2025,
Volume and Issue:
53(1), P. 122 - 137
Published: March 10, 2025
The
signaling
mechanisms
active
within
mesenchymal
stromal
cells
(MSCs)
influence
the
composition
of
microvesicles
(MVs)
and
exosomes
(Exos)
secreted
by
them.
Previously,
we
showed
that
priming
MSCs
with
a
p38
pharmacological
inhibitor
(pMSCs)
rejuvenates
them
improves
their
ability
to
promote
ex
vivo
hematopoietic
stem
cell
(HSC)
expansion.
This
study
examined
whether
pMSCs
exerted
HSC-supportive
via
MVs
(pMVs)
Exos
(pExos).
Our
findings
demonstrate
distinct
regulation
HSC
fate
pMVs
pExos.
promoted
expansion
long-term
HSCs
(LT-HSCs),
distinguished
robust
self-renewal
capacity
superior
engraftment
ability.
In
contrast,
pExos
facilitated
short-term
(ST-HSCs)
high
proliferative
differentiation
potential.
Infusing
combination
pMVs-
pExos-expanded
as
composite
graft
resulted
in
significantly
higher
engraftment,
emphasizing
synergistic
interaction
between
LT-
ST-HSC
populations.
Gene
expression
studies,
functional
phenotypic
experiments
regulate
quiescence
Egr1/Cdkn1a
axis,
while
control
proliferation
Nfya/Cdkn1a
axis.
These
provide
insights
into
molecular
underlying
differential
function
It
also
proposes
strategy
using
"MSC-derived
biologics"
for
improving
transplantation
success.
Cells,
Journal Year:
2025,
Volume and Issue:
14(6), P. 411 - 411
Published: March 11, 2025
Cancer
is
one
of
the
leading
causes
death
worldwide.
Evidence
indicates
that
extracellular
vesicles
are
involved
in
cancer
development
and
may
be
used
as
promising
biomarkers
detection.
Concomitantly,
saliva
constitutes
a
non-invasive
inexpensive
source
biomarkers.
This
systematic
review
investigates
use
salivary
detecting
cancers
located
outside
head
neck.
PubMed,
Web
Science,
Scopus,
Embase
were
thoroughly
searched
from
database
inception
to
16
July
2024.
Data
sixteen
eligible
studies
analyzed,
including
glioblastoma,
lung,
esophageal,
gastric,
prostate,
hepatocellular,
breast,
pancreatobiliary
tract
cancers.
The
findings
highlight
strong
diagnostic
potential
for
lung
esophageal
cancers,
where
specific
exosomal
RNAs
proteins
demonstrated
high
accuracy
distinguishing
patients
healthy
individuals.
Additionally,
glioblastoma
showed
prognostic
value,
while
those
hepatocellular
exhibited
early
However,
gastric
prostate
limited
reliability,
breast
require
further
validation.
In
conclusion,
present
detection
across
multiple
types;
however,
their
power
needs
research,
standardization
large-scale
Frontiers in Microbiology,
Journal Year:
2025,
Volume and Issue:
16
Published: March 20, 2025
Introduction
The
microbiota
has
been
unequivocally
linked
to
various
diseases,
yet
the
mechanisms
underlying
these
associations
remain
incompletely
understood.
One
potential
contributor
this
relationship
is
extracellular
vesicles
produced
by
bacteria
(bEVs).
However,
detection
of
bEVs
challenging.
Therefore,
we
propose
a
novel
workflow
identify
bacterial
RNA
present
in
circulating
using
Total
EV
RNA-seq
data.
As
proof
concept,
applied
dataset
from
individuals
with
multiple
sclerosis
(MS).
Methods
We
analyzed
total
data
blood
samples
healthy
controls
and
MS,
encompassing
both
Relapsing-Remitting
(RR)
Secondary
Progressive
(SP)
phases
disease.
Our
incorporates
reference
mapping
steps
against
host
genome,
followed
consensus
selection
genera
based
on
taxonomic
profiling
tools.
This
approach
utilizes
flagging
system
exclude
low
abundance
across
profilers.
Additionally,
included
EVs
derived
two
cultured
species
that
serve
as
biological
controls,
well
artificially
generated
reads
60
technical
control,
validate
specificity
workflow.
Results
findings
demonstrate
can
indeed
be
detected
samples,
suggesting
powerful
tool
for
reanalyzing
studies.
identified
promising
candidates
differential
expression
between
RR
SP
MS.
Discussion
provides
valuable
insights
into
role
microbiota-host
communication.
Finally,
translatable
other
experiments
RNA,
where
lack
robust
pipeline
lead
an
increased
false
positive
microbial
genera.
instructions
how
use
it
are
available
at
following
repository:
https://github.com/NanoNeuro/EV_taxprofiling
.